Health

Virtue Diagnostics closes $100 million Series B Funding

Virtue Diagnostics, an innovative IVD company, has just announced closing US$100 million in Series B funding. Virtue Diagnostics, founded in 2019, is focused on clinical tests for China and emerging markets. Sequoia China and Morningside Ventures jointly led the investment round with ORIZA Holdings. Existing investors Lilly Asia Ventures and PerkinElmer Ventures participated while HAOYUE Capital was […]

thaipr.net

6 ม.ค. 65

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

Alamar selects Abcam as a key provider of antibody content for its propriety NULISA technology platform Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences research tools, today announced a strategic partnership […]

thaipr.net

4 ม.ค. 65

Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world’s largest vaccine manufacturer by volume, today announced that the Drugs Controller General of India (DCGI) has granted emergency use authorization (EUA) for Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine…

thaipr.net

29 ธ.ค. 64

2020 Global Survey from ISAPS Sees Significant Changes in Aesthetic Procedures During Pandemic

COVID-19 practice closures lead to a 10.9% decrease in surgical procedures The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures today, which showcased the impact of the COVID-19 pandemic on aesthetic plastic surgery procedures worldwide throughout 2020. Highlights  Plastic surgery procedures for aesthetic purposes decreased […]

thaipr.net

29 ธ.ค. 64

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies

– Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants – Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG rise and a 19.9-fold ACE2 inhibition increase after booster dose – Immune responses in adolescents were 2- to […]

thaipr.net

23 ธ.ค. 64
1 … 88 89 90 91 92 … 133

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.